Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Given Average Recommendation of “Hold” by Brokerages
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) has received an average rating of “Hold” from the seven brokerages that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have given a buy recommendation to the company. The average […]
16 Jun 04:15 · The Cerbat Gem